Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nopalea is a wellness brand and product line owned by TriVita, a health and wellness company based in Scottsdale, Arizona. The flagship product is a liquid dietary supplement derived from the fruit of the Nopal cactus (Nopalea cochenillifera), which is marketed for its potent anti-inflammatory and antioxidant properties. The formulation contains bioflavonoids and betalains intended to support the body's immune system and reduce chronic inflammation. Nopalea has been the subject of clinical studies evaluating its impact on joint mobility, flexibility, and inflammatory markers like C-reactive protein. The brand gained significant national attention through infomercials and was involved in a 2014 FTC settlement regarding health claims.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nopalea.